MindWalk Holdings Corp. HYFT
Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026
MindWalk Holdings Corp. (HYFT) is a healthcare company listed in the US with a market value of about $47M. In fiscal year 2025 it had revenue of $18M and net income of -$22M, a net margin of -123.3%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 12% a year, a 5-year average ROIC of -54%.
About MindWalk Holdings
MindWalk Holdings is listed in the US and classified in biotechnology: pharmaceutical preparations. Revenue went from $10M in 2020 to $18M in 2025, growth of about 11.8% a year. It was profitable in 0 of the last 6 years in our data.
Score: 1.2 / 5
Checks passed
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $18M | $18M | $15M | $15M | $15M | $10M |
| Net income | -$22M | -$19M | -$19M | -$13M | -$6M | -$4M |
| Free cash flow | -$5M | -$3M | -$16M | -$9M | -$2M | -$1M |
| EPS (diluted) | $-0.46 | $-0.40 | $-0.41 | $-0.28 | $-0.13 | $-0.07 |
| Net margin | -123.3% | -106.5% | -128.5% | -86.3% | -41.0% | -35.2% |
| ROIC | -128.0% | -73.2% | -45.4% | -16.6% | -8.3% | -32.1% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does MindWalk Holdings pay a dividend?
Not currently.
Is MindWalk Holdings a good stock to buy?
We do not give buy or sell advice. MindWalk Holdings scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.